Pediatric Cancer, Volume 4

Preface. I. Neuroblastoma. 1. Pediatric neuroblastoma: use of hypermethylation of apoptotic genes as a prognostic factor. 2.      Mycn nonamplified neuroblastoma: detection of tumor-derived cell-free dna in serum for predicting prognosis of neuroblastoma. 3.      Neuroblastoma: role of mdm2 and snp309 as markers. 4.  Role of pi3k inhibitors in sensitizing neuroblastoma cells to apoptosis. 5.      Regulation of neuroblastoma cell differentiation by retinoic acid: role of alternative splicing and micro-rnas.6. Neuroblastoma: role of activated leukocyte cell adhesion molecule.7. Neuroblastoma: inhibition by alu-like rna. 8. Children with high risk neuroblastoma: prophylactic and therapeutic treatment with docosahexaenoic acid. II. Medulloblastoma. 9. Overview of treatment of pediatric medulloblastoma.10. Event-free survival of children with average-risk medulloblastoma: treatment with craniospinal radiation followed by adjuvant chemotherapy.III. Leukemia. 11. Risk of childhood acute lymphoblastic leukemia: identification of inherited susceptibility. 12.  Pediatric acute lymphoblastic leukemia: role of bim protein in prednisolone-induced apoptosis.13. Infectious complications of antineoplastic chemotherapy in children with acute leukemia or solid tumors.14. Pediatric leukemia of natural killer cells: diagnosis and multi-agent chemotherapy. IV. Lymphoma. 15. Pediatric lymphoma patients: cytomegalovirus infection.16. Diagnosis of bone marrow involvement in pediatric lymphoma patients: fdg pet/ct versus bone marrow biopsy.17. Survivors of childhood hodgkin's disease after treatment: subsequent solid tumor malignancies based on gender and radiation dose.V. Rhabdoid. 18. Early childhood paraspinal atypical teratoid/rhabdoid tumor:failure of standard treatments. 19. Cerebral tumor with rhabdoid features. 20. Atypical teratoid/rhabdoid tumor of the pineal region: diagnosis. VI. Sarcoma. 21. Ewing's sarcoma family of tumors: targeting molecular pathways and the race for a cure.